Compare · OPCH vs PIII
OPCH vs PIII
Side-by-side comparison of Option Care Health Inc. (OPCH) and P3 Health Partners Inc. (PIII): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both OPCH and PIII operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- OPCH is the larger of the two at $4.09B, about 20.9x PIII ($195.4M).
- OPCH has been more active in the news (4 items in the past 4 weeks vs 2 for PIII).
- OPCH has more recent analyst coverage (13 ratings vs 5 for PIII).
- Company
- Option Care Health Inc.
- P3 Health Partners Inc.
- Price
- $28.41-0.49%
- $2.71-4.24%
- Market cap
- $4.09B
- $195.4M
- 1M return
- -0.28%
- -
- 1Y return
- -13.83%
- -
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2021
- News (4w)
- 4
- 2
- Recent ratings
- 13
- 5
Option Care Health Inc.
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides immunoglobulin infusion therapies for the treatment of immune deficiencies; anti-infective therapies and services; home infusion services to treat heart failures; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders; and immunoglobulin infusion therapies. It also offers infusion therapies for bleeding disorders; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications. In addition, the company offers therapies that women need to survive and thrive through high-risk pregnancies; treatments to manage the progression of neurological disorders, such as amyotrophic lateral sclerosis and duchenne muscular dystrophy; and nursing services. The company is headquartered in Bannockburn, Illinois.
P3 Health Partners Inc.
P3 Health Partners Inc. provides primary health care services. The company offers clinical operations and population health management services, as well as provides senior wellness centers. The company is based in Henderson, Nevada.
Latest OPCH
- Chief Medical Officer Adewunmi Femi covered exercise/tax liability with 1,396 shares, decreasing direct ownership by 5% to 25,314 units (SEC Form 4)
- SEC Form DEFA14A filed by Option Care Health Inc.
- SEC Form DEF 14A filed by Option Care Health Inc.
- Option Care Health to Announce First Quarter 2026 Financial Results and Host Conference Call
- Option Care Health Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits
- Amendment: SEC Form SCHEDULE 13G/A filed by Option Care Health Inc.
- Chief Human Resources Officer Bavaro Michael sold $198,000 worth of shares (6,000 units at $33.00), decreasing direct ownership by 15% to 33,249 units (SEC Form 4)
- Director Pate R Carter sold $970,620 worth of shares (30,287 units at $32.05), decreasing direct ownership by 72% to 11,623 units (SEC Form 4)
- Chief Operating Officer Whitworth Luke covered exercise/tax liability with 4,605 shares, decreasing direct ownership by 3% to 169,589 units (SEC Form 4)
- Chief Growth Officer Grashoff Christopher L. covered exercise/tax liability with 1,980 shares, decreasing direct ownership by 4% to 44,092 units (SEC Form 4)
Latest PIII
- SEC Form PRE 14A filed by P3 Health Partners Inc.
- P3 Health Partners Schedules First Quarter 2026 Earnings Release and Conference Call
- SEC Form S-8 filed by P3 Health Partners Inc.
- SEC Form 10-K filed by P3 Health Partners Inc.
- P3 Health Partners Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- P3 Health Partners Announces Fourth Quarter and Full Year 2025 Results
- P3 Health Partners Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits
- P3 Health Partners Schedules Fourth Quarter and Full Year 2025 Earnings Release and Conference Call
- P3 Health Partners Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits
- Amendment: Director Wasson Gregory D was granted 2,000 units of Class A Common Stock, increasing direct ownership by 46% to 6,331 units (SEC Form 4)